Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -70.58B | 113.56%50.9B | -0.42%23.84B | -38.04%23.94B | -27.78%38.63B | 37.36%53.49B | 633.70%38.94B | 80.25%-7.3B | -30.93%-36.94B | -262.83%-28.22B |
Net profit before non-cash adjustment | --8.89B | 15.43%37.5B | 23.38%32.48B | 425.05%26.33B | -86.60%5.01B | -0.07%37.41B | 17.39%37.43B | 13.71%31.89B | 4.23%28.04B | 12.10%26.91B |
Total adjustment of non-cash items | ---20.55B | 1,236.80%22.08B | -93.53%1.65B | 1,663.93%25.54B | -65.28%-1.63B | -106.53%-988M | -36.83%15.12B | 588.21%23.94B | -56.72%3.48B | 171.58%8.04B |
-Depreciation and amortization | --3.31B | 9.35%12.57B | 2.48%11.5B | 7.05%11.22B | 14.05%10.48B | -7.26%9.19B | -3.53%9.91B | 1.51%10.27B | 4.66%10.12B | -6.08%9.67B |
-Reversal of impairment losses recognized in profit and loss | ---- | 13.66%491M | -83.29%432M | 1,009.87%2.59B | 82.03%233M | 3,100.00%128M | -99.66%4M | 306.87%1.18B | --291M | ---- |
-Disposal profit | --165M | -123.64%-620M | -13.55%2.62B | 149.10%3.03B | 2.01%1.22B | 220.12%1.19B | -612.37%-994M | 101.51%194M | -1,557.49%-12.83B | 93.57%-774M |
-Other non-cash items | ---24.03B | 174.71%9.64B | -248.33%-12.9B | 164.12%8.7B | -17.95%-13.57B | -285.50%-11.5B | -49.53%6.2B | 108.38%12.28B | 785.47%5.9B | -118.26%-860M |
Changes in working capital | ---58.92B | 15.76%-8.68B | 63.13%-10.3B | -179.24%-27.93B | 106.50%35.25B | 225.40%17.07B | 78.44%-13.61B | 7.81%-63.12B | -8.41%-68.47B | -555.62%-63.16B |
-Change in receivables | ---54.83B | 5.40%-9.69B | 61.79%-10.24B | -341.42%-26.81B | 0.27%11.11B | 166.14%11.08B | 72.75%-16.75B | 14.98%-61.45B | -21.01%-72.27B | -259.80%-59.72B |
-Change in inventory | ---1.37B | -327.23%-1.91B | -124.20%-448M | -1.33%1.85B | 160.92%1.88B | -65.73%719M | -4.33%2.1B | -21.68%2.19B | -32.45%2.8B | 111.05%4.15B |
-Change in payables | ---2.07B | 223.75%1.01B | -543.31%-817M | -113.23%-127M | 131.11%960M | -44.95%-3.09B | 38.98%-2.13B | 58.80%-3.49B | -215.62%-8.47B | 9.75%-2.68B |
-Provision for loans, leases and other losses | ---655M | 58.46%1.92B | 142.57%1.21B | -113.35%-2.85B | 154.82%21.31B | 164.29%8.36B | 928.27%3.16B | -104.03%-382M | 293.48%9.47B | -161.38%-4.9B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -556M | -24.81%-1.82B | -12.66%-1.46B | -3.77%-1.3B | 7.00%-1.25B | 8.08%-1.34B | 3.82%-1.46B | 10.28%-1.52B | 6.57%-1.69B | 4.98%-1.81B |
Interest received (cash flow from operating activities) | 272M | 21.14%361M | 33.04%298M | -17.65%224M | 16.74%272M | -1.69%233M | -35.07%237M | 4.29%365M | -9.79%350M | -18.32%388M |
Tax refund paid | -5.4B | -92.06%-11.44B | 48.12%-5.96B | 32.29%-11.48B | -35.94%-16.96B | -10.14%-12.47B | -4.10%-11.33B | -41.85%-10.88B | -35.20%-7.67B | -58.20%-5.67B |
Other operating cash inflow (outflow) | 0 | 1M | 0 | -90.90%136M | 149,500.00%1.49B | -200.00%-1M | 0.00%1M | 1M | 0 | 200.00%1M |
Operating cash flow | ---76.26B | 127.33%38B | 45.13%16.72B | -48.10%11.52B | -44.39%22.19B | 51.19%39.91B | 236.56%26.4B | 57.94%-19.33B | -30.15%-45.96B | -386.84%-35.31B |
Investing cash flow | ||||||||||
Net investment product transactions | ---1.45B | 67.71%-2.11B | -96.13%-6.54B | 8.18%-3.34B | 58.82%-3.63B | -49.64%-8.82B | -187.10%-5.9B | 318.61%6.77B | -39.26%1.62B | -43.99%2.66B |
Net changes in other investments | ---4.22B | -1.98%-16.15B | -51.95%-15.84B | 17.32%-10.42B | -9.71%-12.61B | -244.48%-11.49B | 44.60%-3.34B | -1,693.12%-6.02B | 105.62%378M | 21.98%-6.73B |
Investing cash flow | ---5.67B | 18.39%-18.27B | -62.66%-22.38B | 15.28%-13.76B | 20.05%-16.24B | -120.05%-20.32B | -1,335.88%-9.23B | -62.56%747M | 149.10%2B | -5.07%-4.06B |
Financing cash flow | ||||||||||
Net issuance payments of debt | --98.07B | -80.10%11.07B | 30.77%55.64B | 817.46%42.55B | 167.18%4.64B | -674.85%-6.9B | -97.64%1.2B | -32.03%50.9B | -7.93%74.89B | 529.90%81.33B |
Net common stock issuance | ---5B | 87.05%-3.37B | 14.91%-26B | -3,055,800.00%-30.56B | 99.99%-1M | -12.60%-7.89B | 53.32%-7.01B | 27.50%-15.02B | 40.88%-20.71B | -133.32%-35.04B |
Cash dividends paid | ---9.62B | -38.19%-15.21B | 0.11%-11.01B | -9.06%-11.02B | 13.89%-10.1B | -24.11%-11.73B | -18.85%-9.45B | -24.54%-7.95B | -18.46%-6.39B | -9.42%-5.39B |
Net other fund-raising expenses | ---109M | 0.00%-376M | -82.52%-376M | -52.59%-206M | -112.98%-135M | 267.74%1.04B | -292.41%-620M | 0.00%-158M | 15.96%-158M | 20.34%-188M |
Financing cash flow | --83.34B | -143.15%-7.88B | 2,271.30%18.26B | 113.75%770M | 78.03%-5.6B | -60.50%-25.49B | -157.18%-15.88B | -41.69%27.77B | 16.97%47.63B | 660.33%40.72B |
Net cash flow | ||||||||||
Beginning cash position | --64.56B | 32.02%52.42B | -3.57%39.71B | 0.86%41.18B | -12.61%40.83B | 2.82%46.72B | 25.36%45.44B | 11.27%36.25B | 4.31%32.58B | 3.91%31.23B |
Current changes in cash | --1.41B | -5.84%11.86B | 956.15%12.59B | -517.90%-1.47B | 105.97%352M | -558.96%-5.89B | -86.03%1.28B | 150.44%9.19B | 172.66%3.67B | 14.46%1.35B |
Cash adjustments other than cash changes | ---1M | 136.13%281M | --119M | ---- | ---- | ---- | -200.00%-1M | --1M | ---- | ---- |
End cash Position | --65.97B | 23.16%64.56B | 32.02%52.42B | -3.57%39.71B | 0.86%41.18B | -12.61%40.83B | 2.82%46.72B | 25.36%45.44B | 11.27%36.25B | 4.31%32.58B |
Free cash flow | ---76.26B | 127.33%38B | 45.13%16.72B | -48.10%11.52B | -44.39%22.19B | 51.19%39.91B | 236.56%26.4B | 57.94%-19.33B | -30.15%-45.96B | -386.84%-35.31B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |